These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study. Shiomi H, Nakagawa Y, Morimoto T, Furukawa Y, Nakano A, Shirai S, Taniguchi R, Yamaji K, Nagao K, Suyama T, Mitsuoka H, Araki M, Takashima H, Mizoguchi T, Eisawa H, Sugiyama S, Kimura T, CREDO-Kyoto AMI investigators. BMJ; 2012 May 23; 344():e3257. PubMed ID: 22623632 [Abstract] [Full Text] [Related]
27. The usefulness of myeloperoxidase in prediction of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Stankovic S, Asanin M, Majkic-Singh N, Ignjatovic S, Mihailovic M, Nikolajevic I, Mrdovic I, Matic D, Savic L, Marinkovic J, Ostojic M, Vasiljevic Z. Clin Lab; 2012 May 23; 58(1-2):125-31. PubMed ID: 22372355 [Abstract] [Full Text] [Related]
35. Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Tjandrawidjaja MC, Fu Y, Westerhout CM, Wagner GS, Granger CB, Armstrong PW, APEX-AMI Investigators. Am J Cardiol; 2010 Sep 01; 106(5):630-4. PubMed ID: 20723636 [Abstract] [Full Text] [Related]
36. Impact of multivessel coronary artery disease on early ischemic injury, late clinical outcome, and remodeling in patients with acute myocardial infarction treated by primary coronary angioplasty. Tarantini G, Napodano M, Gasparetto N, Favaretto E, Marra MP, Cacciavillani L, Bilato C, Osto E, Cademartiri F, Musumeci G, Corbetti F, Razzolini R, Iliceto S. Coron Artery Dis; 2010 Mar 01; 21(2):78-86. PubMed ID: 20071979 [Abstract] [Full Text] [Related]
37. Early ST-segment recovery after primary percutaneous coronary intervention accurately predicts long-term prognosis after acute myocardial infarction. Verouden NJ, Haeck JD, Kuijt WJ, Koch KT, Henriques JP, Baan J, Vis MM, Piek JJ, Tijssen JG, de Winter RJ. Am Heart J; 2010 Jun 01; 159(6):1005-11. PubMed ID: 20569713 [Abstract] [Full Text] [Related]
38. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE). Jang IK, Weissman NJ, Picard MH, Zile MR, Pettigrew V, Shen S, Tatsuno J, Hibberd MG, Tzivoni D, Wackers FJ, EVOLVE Investigators. Am Heart J; 2008 Jan 01; 155(1):113.e1-8. PubMed ID: 18082500 [Abstract] [Full Text] [Related]
39. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM. Am J Cardiol; 2012 Feb 15; 109(4):486-91. PubMed ID: 22100027 [Abstract] [Full Text] [Related]
40. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G. Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]